Unifi Capital, a Chennai-based asset management firm known for its value-driven investment philosophy, has exited its position in Marksans Pharma Ltd., a mid-cap pharmaceutical company. The move signals a broader rebalancing of the fund’s portfolio as it reassesses sectoral exposure and redeploys capital into new opportunities. While the sale may raise questions about Marksans Pharma’s near-term prospects, market watchers interpret the transaction as a routine investment rotation rather than a bearish outlook.